Browsing byAuthorHawkins, CL

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 5 to 12 of 12< previous 
Issue DateTitleAuthor(s)
2017-08-01Catalytic oxidant scavenging by selenium-containing compounds: Reduction of selenoxides and N-chloramines by thiols and redox enzymesCarroll, L; Pattison, DI; Fu, S; Schiesser, CH; Davies, MJ; Hawkins, CL
2015-05-01Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosisIsmael, FO; Proudfoot, JM; Brown, BE; Van Reyk, DM; Croft, KD; Davies, MJ; Hawkins, CL
2014-04-22Glutathionylation mediates angiotensin II-induced eNOS uncoupling, amplifying NADPH oxidase-dependent endothelial dysfunction.Galougahi, KK; Liu, C-C; Gentile, C; Kok, C; Nunez, A; Garcia, A; Fry, NAS; Davies, MJ; Hawkins, CL; Rasmussen, HH; Figtree, GA
2008-09-01Hypothiocyanous acid is a more potent inducer of apoptosis and protein thiol depletion in murine macrophage cells than hypochlorous acid or hypobromous acidLloyd, MM; van Reyk, DM; Davies, MJ; Hawkins, CL
2017-10-01Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunctionAbdo, AI; Rayner, BS; van Reyk, DM; Hawkins, CL
2010-08-15The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages.Lane, AE; Tan, JTM; Hawkins, CL; Heather, AK; Davies, MJ
2018-03-15A pivotal role for NF-κB in the macrophage inflammatory response to the myeloperoxidase oxidant hypothiocyanous acidPan, GJ; Rayner, BS; Zhang, Y; van Reyk, DM; Hawkins, CL
2016-02-19β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.Karimi Galougahi, K; Liu, C-C; Garcia, A; Gentile, C; Fry, NA; Hamilton, EJ; Hawkins, CL; Figtree, GA